IκB kinase phosphorylates cytoplasmic TDP-43 and promotes its proteasome degradation

Author:

Iguchi Yohei1ORCID,Takahashi Yuhei1ORCID,Li Jiayi1ORCID,Araki Kunihiko12ORCID,Amakusa Yoshinobu1ORCID,Kawakami Yu1ORCID,Kobayashi Kenta3ORCID,Yokoi Satoshi1ORCID,Katsuno Masahisa14ORCID

Affiliation:

1. Nagoya University Graduate School of Medicine 1 Department of Neurology, , Nagoya, Japan

2. University of Bonn 2 Medical Faculty, Institute of Experimental Epileptology and Cognition Research, , Bonn, Germany

3. National Institute for Physiological Sciences 4 Section of Viral Vector Development, , Okazaki, Japan

4. Nagoya University Graduate School of Medicine 3 Department of Clinical Research Education, , Nagoya, Japan

Abstract

Cytoplasmic aggregation of TDP-43 in neurons is a pathological feature common to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). We demonstrate that the IκB kinase (IKK) complex promotes the degradation of cytoplasmic TDP-43 through proteasomes. While IKKβ is a major factor in TDP-43 degradation, IKKα acts as a cofactor, and NEMO functions as a scaffold for the recruitment of TDP-43 to the IKK complex. Furthermore, we identified IKKβ-induced phosphorylation sites of TDP-43 and found that phosphorylation at Thr8 and Ser92 is important for the reduction of TDP-43 by IKK. TDP-43 phosphorylation at Ser92 was detected in a pattern different from that of C-terminal phosphorylation in the pathological inclusion of ALS. IKKβ was also found to significantly reduce the expression level and toxicity of the disease-causing TDP-43 mutation. Finally, the favorable effect of IKKβ on TDP-43 aggregation was confirmed in the hippocampus of mice. IKK and the N-terminal phosphorylation of TDP-43 are potential therapeutic targets for ALS and FTLD.

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

SERIKA

Japan ALS Association

Takeda Science Foundation

Publisher

Rockefeller University Press

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3